Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 1
1993 2
1999 1
2000 1
2001 1
2002 2
2003 2
2005 5
2006 4
2007 4
2008 2
2009 1
2010 2
2011 1
2012 1
2013 4
2014 1
2015 3
2017 1
2018 1
2019 1
2020 3
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

43 results
Results by year
Filters applied: . Clear all
Page 1
Dyslipidaemia in type 2 diabetes mellitus: bad for the heart.
Katsiki N, Tentolouris N, Mikhailidis DP. Katsiki N, et al. Curr Opin Cardiol. 2017 Jul;32(4):422-429. doi: 10.1097/HCO.0000000000000407. Curr Opin Cardiol. 2017. PMID: 28362666 Review.
These patients are also more prone to heart failure, arrhythmias and sudden cardiac death. Furthermore, coronary interventions performed in such high-risk patients have worse outcomes. ...
These patients are also more prone to heart failure, arrhythmias and sudden cardiac death. Furthermore, coronary interventions perfor …
The emerging role of dyslipidemia in diabetic microvascular complications.
Savelieff MG, Callaghan BC, Feldman EL. Savelieff MG, et al. Curr Opin Endocrinol Diabetes Obes. 2020 Apr;27(2):115-123. doi: 10.1097/MED.0000000000000533. Curr Opin Endocrinol Diabetes Obes. 2020. PMID: 32073426 Review.
These molecular studies are identifying possible targets for therapeutic intervention. Complementing molecular research, lifestyle interventions are on-going to assess whether dietary choices and/or exercise, weight-loss, or surgical interventions, such as bariatric …
These molecular studies are identifying possible targets for therapeutic intervention. Complementing molecular research, lifestyle interv
Diabetic Kidney Disease in Older People with Type 2 Diabetes Mellitus: Improving Prevention and Treatment Options.
Abdelhafiz AH. Abdelhafiz AH. Drugs Aging. 2020 Aug;37(8):567-584. doi: 10.1007/s40266-020-00773-y. Drugs Aging. 2020. PMID: 32495289 Review.
The management includes promotion of a healthy lifestyle and control of cardiovascular risk factors such as hyperglycaemia, hypertension and dyslipidaemia. Older people are a heterogeneous group of people from a community-living fit and independent person to a fully depend …
The management includes promotion of a healthy lifestyle and control of cardiovascular risk factors such as hyperglycaemia, hypertension and …
Metabolic syndrome in young people.
Poyrazoglu S, Bas F, Darendeliler F. Poyrazoglu S, et al. Curr Opin Endocrinol Diabetes Obes. 2014 Feb;21(1):56-63. doi: 10.1097/01.med.0000436414.90240.2c. Curr Opin Endocrinol Diabetes Obes. 2014. PMID: 24247648 Review.
Therefore, the emphasis in all studies and programs related to metabolic syndrome should be focused on prevention, early detection of metabolic risk factors and interventions that will have a significant impact on future adult health....
Therefore, the emphasis in all studies and programs related to metabolic syndrome should be focused on prevention, early detection of metabo …
Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus.
Besseling J, Kastelein JJ, Defesche JC, Hutten BA, Hovingh GK. Besseling J, et al. JAMA. 2015 Mar 10;313(10):1029-36. doi: 10.1001/jama.2015.1206. JAMA. 2015. PMID: 25756439
DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional study in all individuals (n = 63,320) who underwent DNA testing for familial hypercholesterolemia in the national Dutch screening program between 1994 and 2014. EXPOSURES: Deleteriousness and nondeleteriousness of familial …
DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional study in all individuals (n = 63,320) who underwent DNA testing for familial hypercholest …
Atherogenic dyslipidemia and diabetes mellitus: what's new in the management arena?
Kumar A, Singh V. Kumar A, et al. Vasc Health Risk Manag. 2010 Sep 7;6:665-9. doi: 10.2147/vhrm.s5686. Vasc Health Risk Manag. 2010. PMID: 20859538 Free PMC article. Review.
For this reason diabetes is considered a "coronary disease equivalent" condition, as classified by the National Cholesterol Education Program Adult Treatment Panel (NCEP-ATP) III. Furthermore, patients with diabetes who experience a myocardial infarction have a poorer prog …
For this reason diabetes is considered a "coronary disease equivalent" condition, as classified by the National Cholesterol Education Pro
Management of hypercholesterolaemia in the patient with diabetes.
Packard C, Olsson AG. Packard C, et al. Int J Clin Pract Suppl. 2002 Jul;(130):27-32. Int J Clin Pract Suppl. 2002. PMID: 12296606 Review.
Retrospective subgroup analysis and prospective studies have shown that lipid-lowering therapy can slow the progression of atherosclerosis and reduce the risk for cardiovascular events in patients with diabetes, and both the National Cholesterol Education Program Adult Tre …
Retrospective subgroup analysis and prospective studies have shown that lipid-lowering therapy can slow the progression of atherosclerosis a …
43 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page